Join the Vaxart Vaccination Revolution: Key Updates for Investors

Author: Olivia Taylor Updated: 05-29-2025 08:18 AM

Key Updates from Vaxart for Stockholders

In a recent announcement, Dr. Sean Tucker, the Founder and Chief Scientific Officer of Vaxart, Inc. (NASDAQ: VXRT), reached out to stockholders via a video update. The communication is structured to motivate stockholders to participate actively in the company's future directions, particularly the upcoming proposal for a reverse stock split.

Importance of Voting on the Reverse Stock Split Proposal

Dr. Tucker emphasizes the necessity of stockholders voting FOR Proposal No. 2 by the deadline of June 1, 2025, at 11:59 p.m. Eastern Time. This proposal seeks to empower the Board of Directors with the authority to manage the reverse stock split, a strategic move aimed at ensuring Vaxart retains compliance with Nasdaq's minimum bid price rule.

Addressing Common Misconceptions

To further assist investors, Vaxart has developed a fact sheet addressing widespread misconceptions related to the reverse stock split. This resource seeks to clarify important facets of the proposal, ensuring that stockholders can make informed voting decisions. An accompanying PDF is available for more detailed insights and clarification on these complex topics.

Encouragement for Participation

All stockholders of record as of March 26, 2025, are encouraged to review their voting status. Even those who initially voted against Proposal No. 2 can revisit their decision and amend their vote if they choose. The active involvement of stockholders is crucial as Vaxart navigates this important phase of its operational strategy.

Need Assistance? Here to Help!

If assistance is needed regarding the voting procedure, Vaxart is providing support through its proxy solicitation firm, Campaign Management, LLC. You can reach out to them toll-free at 1-855-264-1527 or via email at info@campaign-mgmt.com.

About Vaxart

Vaxart, a pioneering clinical-stage biotechnology company, is at the forefront of developing oral recombinant vaccines based on a unique delivery platform. The innovative nature of Vaxart's vaccines allows for administration in pill form, which can be stored and transported without refrigeration—eliminating the need for syringes and reducing the risk of needle-stick injuries.

The company is currently engaged in numerous development programs, focusing on vaccines addressing key health challenges such as coronavirus, norovirus, and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), marking its entry into immune-oncology.

Frequently Asked Questions

What is the purpose of the video update from Dr. Tucker?

The video update aims to encourage stockholders to vote in favor of the reverse stock split proposal, which is important for maintaining compliance with Nasdaq regulations.

What is the reverse stock split proposal about?

The proposal seeks to give the Board authority to implement a reverse stock split to help Vaxart meet the Nasdaq minimum bid price rule.

How should stockholders vote on the proposal?

Stockholders are encouraged to cast their votes by June 1, 2025, at 11:59 p.m. Eastern Time, with options to change previous votes if necessary.

Where can stockholders find more information about the misconceptions?

A detailed fact sheet accompanying the announcement addresses common misunderstandings regarding the reverse stock split.

How can stockholders get help with the voting process?

For assistance, stockholders can contact Campaign Management, LLC, at 1-855-264-1527 or through email at info@campaign-mgmt.com.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.